Cytopathological Features of SMARCA4-Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature

被引:23
作者
Takeda, Maiko [1 ]
Tani, Yoko [1 ,2 ]
Saijo, Nobuhiko [1 ]
Shimizu, Shigeki [3 ]
Taniguchi, Yoshihiko [1 ]
Otsuka, Kenji [1 ,4 ]
Nakao, Keiko [1 ]
Tamiya, Akihiro [1 ]
Okishio, Kyoichi [1 ]
Atagi, Shinji [1 ]
Ohbayashi, Chiho [5 ]
Kasai, Takahiko [1 ]
机构
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[2] Osaka City Univ, Osaka, Japan
[3] Kinki Univ Med, Osaka, Japan
[4] Tokushima Univ, Tokushima, Japan
[5] Nara Med Univ, Kashihara, Nara, Japan
关键词
SMARCA4-deficient thoracic sarcoma; SWI; SNF complex; rhabdoid cells; imprint cytology; immunohistochemistry; CELL-LINES; BRM;
D O I
10.1177/1066896919870866
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity of thoracic sarcomas with an undifferentiated rhabdoid morphology and SMARCA4 inactivation. Regardless of some reports about the histopathological findings so far, there have been only a few reports about the cytological features. In this article, we present the pathological features of 2 SMARCA4-DTS cases, including the cytological findings. Histopathologically, the tumor cells showed atypical loosely cohesive large epithelioid cells focally with geographic necrosis. Some cells were characterized by rhabdoid cells. Both patients showed intrathoracic masses with a history of smoking, and loss of SMARCA4 expression was confirmed with histopathological specimens. Immunohistochemically, tumor cells of both cases were at least focally positive for cytokeratin, CD34, CD99, synaptophysin, SOX2, and SALL4. In addition, tumor cells demonstrated significantly reduced expression of BRG1/SMARCA4 and SMARCA2. In conclusion, SMARCA4-DTS should be taken into consideration in the differential diagnosis of tumors with undifferentiated rhabdoid morphology involving the thoracic region.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 14 条
[1]   A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma. [J].
Agulnik, Mark ;
Tannir, Nizar M. ;
Pressey, Joseph Gerald ;
Gounder, Mrinal M. ;
Cote, Gregory Michael ;
Roche, Maria ;
Doleman, Susan ;
Blakemore, Stephen J. ;
Clawson, Alicia ;
Daigle, Scott ;
Tang, Jeanie ;
Ho, Peter T. C. ;
Demetri, George D. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[2]   Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer [J].
Fukuoka, J ;
Fujii, T ;
Shih, JH ;
Dracheva, T ;
Meerzaman, D ;
Player, A ;
Hong, K ;
Settnek, S ;
Gupta, A ;
Buetow, K ;
Hewitt, S ;
Travis, WD ;
Jen, J .
CLINICAL CANCER RESEARCH, 2004, 10 (13) :4314-4324
[3]   Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy [J].
Gramling, S. ;
Rogers, C. ;
Liu, G. ;
Reisman, D. .
ONCOGENE, 2011, 30 (29) :3289-3294
[4]   Discovery of BRM Targeted Therapies: Novel Reactivation of an Anticancer Gene [J].
Gramling, Sarah ;
Reisman, David .
LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (01) :93-99
[5]   SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources [J].
Kuwamoto, Satoshi ;
Matsushita, Michiko ;
Takeda, Kenichi ;
Tanaka, Natsumi ;
Endo, Yukari ;
Yamasaki, Akira ;
Kohashi, Kenichi ;
Oda, Yoshinao ;
Horie, Yasushi .
HUMAN PATHOLOGY, 2017, 70 :92-97
[6]   SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas [J].
Le Loarer, Francois ;
Watson, Sarah ;
Pierron, Gaelle ;
de Montpreville, Vincent Thomas ;
Ballet, Stelly ;
Firmin, Nelly ;
Auguste, Aurelie ;
Pissaloux, Daniel ;
Boyault, Sandrine ;
Paindavoine, Sandrine ;
Dechelotte, Pierre Joseph ;
Besse, Benjamin ;
Vignaud, Jean Michel ;
Brevet, Marie ;
Fadel, Elie ;
Richer, Wilfrid ;
Treilleux, Isabelle ;
Masliah-Planchon, Julien ;
Devouassoux-Shisheboran, Mojgan ;
Zalcman, Gerard ;
Allory, Yves ;
Bourdeaut, Franck ;
Thivolet-Bejui, Francoise ;
Ranchere-Vince, Dominique ;
Girard, Nicolas ;
Lantuejoul, Sylvie ;
Galateau-Salle, Francoise ;
Coindre, Jean Michel ;
Leary, Alexandra ;
Delattre, Olivier ;
Blay, Jean Yves ;
Tirode, Franck .
NATURE GENETICS, 2015, 47 (10) :1200-+
[7]   Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors [J].
Matsushita, Michiko ;
Kuwamoto, Satoshi .
ACTA CYTOLOGICA, 2018, 62 (5-6) :456-462
[8]   Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines [J].
Medina, Pedro P. ;
Romero, Octavio A. ;
Kohno, Takashi ;
Montuenga, Luis A. ;
Pio, Ruben ;
Yokota, Jun ;
Sanchez-Cespedes, Montse .
HUMAN MUTATION, 2008, 29 (05) :617-622
[9]   Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRGI, in lung tumors [J].
Medina, PP ;
Carretero, J ;
Fraga, MF ;
Esteller, M ;
Sidransky, D ;
Sanchez-Cespedes, M .
GENES CHROMOSOMES & CANCER, 2004, 41 (02) :170-177
[10]   SMARCA4-deficient Thoracic Sarcomas Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses [J].
Perret, Raul ;
Chalabreysse, Lara ;
Watson, Sarah ;
Serre, Isabelle ;
Garcia, Stephane ;
Forest, Fabien ;
Yvorel, Violaine ;
Pissaloux, Daniel ;
de Montpreville, Vincent Thomas ;
Masliah-planchon, Julien ;
Lantuejoul, Sylvie ;
Brevet, Marie ;
Blay, Jean-Yves ;
Coindre, Jean-Michel ;
Tirode, Franck ;
Le Loarer, Francois .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (04) :455-465